![Adenosine Deaminase (ADA) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis as an Early Feature | Journal of Clinical Immunology Adenosine Deaminase (ADA) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis as an Early Feature | Journal of Clinical Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10875-022-01337-y/MediaObjects/10875_2022_1337_Fig1_HTML.png)
Adenosine Deaminase (ADA) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis as an Early Feature | Journal of Clinical Immunology
![Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID - ScienceDirect Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S232905012100022X-fx1.jpg)
Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID - ScienceDirect
![Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review | Genetics in Medicine Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review | Genetics in Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1097%2F01.GIM.0000105752.80592.A3/MediaObjects/41436_2004_Article_BFgim20042_Fig1_HTML.jpg)
Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review | Genetics in Medicine
![Gene therapy for primary immune deficiencies: a Canadian perspective | Allergy, Asthma & Clinical Immunology | Full Text Gene therapy for primary immune deficiencies: a Canadian perspective | Allergy, Asthma & Clinical Immunology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13223-017-0184-y/MediaObjects/13223_2017_184_Fig1_HTML.gif)
Gene therapy for primary immune deficiencies: a Canadian perspective | Allergy, Asthma & Clinical Immunology | Full Text
![Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency - ScienceDirect Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121010612-grabsf1.jpg)